BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Compression Garments and Stockings Market is projected to reach US$ 3.9 Billion by 2029 - Comprehensive Research Report by FMI

  DUBAI, United Arab Emirates, Expanding at a CAGR of 4.9%, the global Compression Garments and Stockings Market is expected to increase from a valuation of US$ 2.8 Bn in 2022 to US$ 3.9 Bn by 2029.

  March 2, 2022

   · 

  5 min read
• Combination Vaccines Market: Increase in the prevalence of infectious diseases to drive the market

  A combination vaccine is a mixture of two or more than two vaccines that could be administered separately, which is put into a single shot.

  March 2, 2022

   · 

  5 min read
• Genetown

  Apellis Pharmaceuticals to Present at Upcoming Investor Conferences - Mar 02, 2022

  Apellis Pharmaceuticals, Inc., a global biopharmaceutical company and leader in complement, announced that the company will participate in the following investor conferences in March.

  March 2, 2022

   · 

  1 min read
• ProMIS Neurosciences’ PMN310 antibody demonstrates significant cognitive benefit in a mouse model of Alzheimer’s disease

  ProMIS Neurosciences, Inc. announced that PMN310, its lead antibody therapeutic candidate for Alzheimer’s disease, showed a significant cognitive benefit in a widely recognized animal model of AD.

  March 2, 2022

   · 

  4 min read
• Business

  IsoPlexis Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Revenue Outlook for 2022 2021 revenue increased 66% over prior year period

  IsoPlexis Corporation (Nasdaq: ISO), the Superhuman Cell Company, today reported financial results for the quarter and year ended December 31, 2021.

  March 2, 2022

   · 

  9 min read
• Genetown

  Kymera Therapeutics to Participate in Upcoming March 2022 Investor Conferences

  Kymera Therapeutics, Inc. announced that the Company will participate in the following upcoming virtual investor conferences:

  March 2, 2022

   · 

  1 min read
• Drug Development

  Elgan Pharma Announces Positive Results from its Phase III Study of ELGN-GI in Preterm Infants for Treatment of Intestinal Malabsorption

  Elgan Pharma announced today outstanding results from a Phase III study evaluating the safety and efficacy of ELGN-GI, a proprietary enteral insulin formulation for the treatment of intestinal malabsorption, that causes feeding intolerance in preterm infants.

  March 2, 2022

   · 

  7 min read
• Pharm Country

  Soligenix to Present at the Q1 Virtual Investor Summit

  Soligenix, Inc. announced today that its Senior Vice President and Chief Financial Officer, Jonathan Guarino , has been invited to attend the Q1 Virtual Investor Summit.

  March 2, 2022

   · 

  5 min read
• Genetown

  Ironwood Pharmaceuticals to Present at Upcoming Investor Conferences in March 2022

  Ironwood Pharmaceuticals, Inc., a GI-focused healthcare company, announced that management will be presenting at the following investor conferences:

  March 2, 2022

   · 

  1 min read
• Biotech Bay

  Oncology Pharma Reports on Progress with Ribera Solutions

  Oncology Pharma Inc. is pleased to announce progress with its investment with Ribera Solutions’ Connect2Med.

  March 2, 2022

   · 

  4 min read